159 related articles for article (PubMed ID: 35658769)
1. Pretreatment Body Mass Index (BMI) as an Independent Prognostic Factor in Nasopharyngeal Carcinoma Survival: A Systematic Review and Meta-Analysis.
Jin X; Hu R; Guo H; Ding C; Pi G; Tian M
Nutr Cancer; 2022; 74(10):3457-3467. PubMed ID: 35658769
[TBL] [Abstract][Full Text] [Related]
2. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH
Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma: A systematic review and meta-analysis.
Hong X; Wang G; Xu G; Shi W; Wang T; Rong Z; Mo C
Medicine (Baltimore); 2022 Jan; 101(3):e28507. PubMed ID: 35060503
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
Su L; Zhang M; Zhang W; Cai C; Hong J
Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis.
Zhang M; Wei S; Su L; Lv W; Hong J
Medicine (Baltimore); 2016 Aug; 95(35):e4494. PubMed ID: 27583859
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
Tu X; Ren J; Zhao Y
Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
[TBL] [Abstract][Full Text] [Related]
8. The obesity paradox in patients with colorectal cancer: a systematic review and meta-analysis.
Li Y; Li C; Wu G; Yang W; Wang X; Duan L; Niu L; Chen J; Zhang Y; Zhou W; Liu J; Hong L; Fan D
Nutr Rev; 2022 Jun; 80(7):1755-1768. PubMed ID: 35182150
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
Zhang Y; Yang X
Dis Markers; 2018; 2018():1034037. PubMed ID: 30510601
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
Lammers SWM; Thurisch H; Vriens IJH; Meegdes M; Engelen SME; Erdkamp FLG; Dercksen MW; Vriens BEPJ; Aaldering KNA; Pepels MJAE; van de Winkel LMH; Peters NAJB; Tol J; Heijns JB; van de Wouw AJ; Teeuwen NJA; Geurts SME; Tjan-Heijnen VCG
Breast Cancer Res Treat; 2024 Jan; 203(2):339-349. PubMed ID: 37878148
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Impact of Body Mass Index in Patients with Diffuse Large B-Cell Lymphoma: A Meta-Analysis.
Wang Z; Luo S; Zhao X
Nutr Cancer; 2021; 73(11-12):2336-2346. PubMed ID: 32964748
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of systemic immune-inflammation index in patients with nasopharyngeal carcinoma: a meta-analysis.
Zeng Z; Xu S; Wang D; Qin G
Syst Rev; 2022 Nov; 11(1):247. PubMed ID: 36403072
[TBL] [Abstract][Full Text] [Related]
13. Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma.
Lin C; Lin K; Zhang B; Su Y; Guo Q; Lu T; Xu Y; Lin S; Zong J; Pan J
Oncologist; 2022 Apr; 27(4):e340-e349. PubMed ID: 35380720
[TBL] [Abstract][Full Text] [Related]
14. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Pretreatment Prognostic Nutritional Index (PNI) in Patients with Nasopharyngeal Carcinoma: A Meta-Analysis.
Gao QL; Shi JG; Huang YD
Nutr Cancer; 2021; 73(9):1657-1667. PubMed ID: 32924631
[TBL] [Abstract][Full Text] [Related]
16. Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: A population-based patient cohort study in southern China.
Du Y; Feng R; Chang ET; Yin L; Huang T; Li Y; Zhou X; Huang Y; Zhou F; Su C; Xiao X; Jia W; Zheng Y; Adami HO; Zeng Y; Cai Y; Zhang Z; Xu M; Ye W
Int J Cancer; 2023 Jul; 153(2):290-301. PubMed ID: 36965052
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Body Mass Index and Survival of Nasopharyngeal Carcinoma by Propensity-Matched Analysis: An Observational Case-Control Study.
OuYang PY; Zhang LN; Tang J; Lan XW; Xiao Y; Gao YH; Ma J; Xie FY
Medicine (Baltimore); 2016 Jan; 95(2):e2380. PubMed ID: 26765414
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of prognostic nutritional index in nasopharyngeal carcinoma: A systematic review and meta-analysis.
Tang M; Jia Z; Zhang J
Int J Clin Oncol; 2021 Jan; 26(1):66-77. PubMed ID: 33029749
[TBL] [Abstract][Full Text] [Related]
19. Body mass index, body shape, and risk of nasopharyngeal carcinoma: A population-based case-control study in Southern China.
Feng R; Chang ET; Liu Z; Liu Q; Cai Y; Zhang Z; Chen G; Huang QH; Xie SH; Cao SM; Zhang Y; Yun J; Jia WH; Zheng Y; Liao J; Chen Y; Lin L; Ernberg I; Huang G; Zeng Y; Zeng YX; Adami HO; Ye W
Cancer Med; 2019 Apr; 8(4):1835-1844. PubMed ID: 30793524
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of neutrophil-to-lymphocyte ratio for nasopharyngeal carcinoma: A meta-analysis.
Yin J; Qin Y; Luo YK; Feng M; Lang JY
Medicine (Baltimore); 2017 Jul; 96(29):e7577. PubMed ID: 28723793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]